Rowan Pentz

610 total citations
12 papers, 432 citations indexed

About

Rowan Pentz is a scholar working on Physiology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rowan Pentz has authored 12 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rowan Pentz's work include Alzheimer's disease research and treatments (6 papers), Down syndrome and intellectual disability research (3 papers) and Tryptophan and brain disorders (3 papers). Rowan Pentz is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Down syndrome and intellectual disability research (3 papers) and Tryptophan and brain disorders (3 papers). Rowan Pentz collaborates with scholars based in Canada, United Kingdom and Italy. Rowan Pentz's co-authors include A. Claudio Cuello, M. Florencia Iulita, Hélène Hall, Adriana Ducatenzeiler, Melanie Clarke, Shawn Hayley, Lisi Flores Aguilar, David A. Bennett, Zach Dwyer and Darcy Litteljohn and has published in prestigious journals such as PLoS ONE, Journal of Neurochemistry and Molecular Psychiatry.

In The Last Decade

Rowan Pentz

12 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rowan Pentz Canada 10 182 125 98 92 90 12 432
Shi-Jie Liu United States 11 218 1.2× 166 1.3× 217 2.2× 58 0.6× 58 0.6× 11 587
Helena Passarelli Giroud Joaquim Brazil 14 191 1.0× 70 0.6× 150 1.5× 56 0.6× 66 0.7× 36 476
Jinhao Sun China 12 69 0.4× 110 0.9× 200 2.0× 33 0.4× 53 0.6× 33 426
Megumi Asada‐Utsugi Japan 11 238 1.3× 126 1.0× 172 1.8× 31 0.3× 136 1.5× 19 514
Diane Jansen Netherlands 13 264 1.5× 94 0.8× 88 0.9× 22 0.2× 129 1.4× 16 490
Beverly M. Francis Canada 6 200 1.1× 182 1.5× 102 1.0× 54 0.6× 94 1.0× 7 412
Laura Mahady United States 8 138 0.8× 115 0.9× 128 1.3× 42 0.5× 65 0.7× 11 340
Hannah Brautigam United States 6 239 1.3× 120 1.0× 67 0.7× 36 0.4× 119 1.3× 8 401
Ashwin Venkataraman United Kingdom 10 182 1.0× 81 0.6× 127 1.3× 29 0.3× 125 1.4× 18 465
Pooneh Memar Ardestani United States 9 113 0.6× 158 1.3× 211 2.2× 40 0.4× 95 1.1× 16 483

Countries citing papers authored by Rowan Pentz

Since Specialization
Citations

This map shows the geographic impact of Rowan Pentz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowan Pentz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowan Pentz more than expected).

Fields of papers citing papers by Rowan Pentz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rowan Pentz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowan Pentz. The network helps show where Rowan Pentz may publish in the future.

Co-authorship network of co-authors of Rowan Pentz

This figure shows the co-authorship network connecting the top 25 collaborators of Rowan Pentz. A scholar is included among the top collaborators of Rowan Pentz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rowan Pentz. Rowan Pentz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
3.
Pentz, Rowan, M. Florencia Iulita, Adriana Ducatenzeiler, David A. Bennett, & A. Claudio Cuello. (2020). The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease. Molecular Psychiatry. 26(10). 6023–6037. 41 indexed citations
4.
Pentz, Rowan, M. Florencia Iulita, Adriana Ducatenzeiler, et al.. (2020). Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study. Alzheimer s & Dementia. 17(4). 605–617. 25 indexed citations
5.
Cuello, A. Claudio, Rowan Pentz, & Hélène Hall. (2019). The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology. Frontiers in Neuroscience. 13. 62–62. 69 indexed citations
6.
Iulita, M. Florencia, Aravind Ganesh, Rowan Pentz, et al.. (2019). Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis. Journal of Alzheimer s Disease. 67(1). 327–341. 34 indexed citations
7.
Caraci, Filippo, M. Florencia Iulita, Rowan Pentz, et al.. (2017). Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome. European Journal of Pharmacology. 817. 7–19. 14 indexed citations
8.
Iulita, M. Florencia, Rowan Pentz, Lisi Flores Aguilar, et al.. (2017). Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease. Neurobiology of Disease. 108. 307–323. 66 indexed citations
9.
Clarke, Melanie, Zach Dwyer, Darcy Litteljohn, et al.. (2016). Ketamine modulates hippocampal neurogenesis and pro-inflammatory cytokines but not stressor induced neurochemical changes. Neuropharmacology. 112(Pt A). 210–220. 69 indexed citations
10.
Iulita, M. Florencia, Alison Ower, Concetta Barone, et al.. (2016). An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation. Alzheimer s & Dementia. 12(11). 1132–1148. 70 indexed citations
11.
Hayley, Shawn, et al.. (2016). The interactive effects of ketamine and magnesium upon depressive-like pathology. Neuropsychiatric Disease and Treatment. Volume 12. 2049–2056. 5 indexed citations
12.
Clarke, Melanie, et al.. (2012). Stressor-Like Effects of c-Jun N-Terminal Kinase (JNK) Inhibition. PLoS ONE. 7(8). e44073–e44073. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shi-Jie Liu Breakdown of academic impact, for papers by Helena Passarelli Giroud Joaquim Breakdown of academic impact, for papers by Jinhao Sun Breakdown of academic impact, for papers by Megumi Asada‐Utsugi Breakdown of academic impact, for papers by Diane Jansen Breakdown of academic impact, for papers by Beverly M. Francis Breakdown of academic impact, for papers by Laura Mahady Breakdown of academic impact, for papers by Hannah Brautigam Breakdown of academic impact, for papers by Ashwin Venkataraman Breakdown of academic impact, for papers by Pooneh Memar Ardestani
Rankless by CCL
2026